Testing and Diagnosis

Regular testing increases the likelihood of cancer being detected at an early stage when there are more treatment options and the chance of cure is highest. Explore these areas to learn about testing and diagnosis for prostate cancer:
 
Digital Rectal
Exam
      Biopsy    

Imaging
Technology

 
Grading Staging
 

The PSA Test

The PSA test is a simple blood test, taken from the arm, which measures the amount of PSA (prostate-specific antigen) protein in the blood. Higher levels of PSA may indicate the presence of cancer, but can also be an indicator of other prostate conditions. Explore the tabs on the left to learn more about PSA testing.
 



Learn more about prostate cancer 'Testing and Diagnosis' from experts in the field.








 
Learn More:

About the PSA test | Recommendations | FAQs
 

For more information and support:





Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Discovery of a promising new medication to block 'master key' of cancer growth

Vancouver, BC – For years, researchers have investigated approaches to prevent cancer-causing cells from multiplying in the body.
More

RFP: Content Development and Delivery of an Accredited Electronic Continuing Medical Education Course for Prostate Cancer Specialists

Prostate Cancer Canada invites applications from service providers interested in the development, promotion and delivery of an accredited electronic Continuing Medical Education course targeting prostate cancer specialists, including urologists.
More

Prostate Cancer Canada announces new President and CEO

Toronto, December 21, 2017 – After five successful years under the leadership and guidance of outgoing President and CEO, Rocco Rossi, Prostate Cancer Canada (PCC) is excited to announce the appointment of a most worthy successor in Peter Coleridge, past national CEO of the Canadian Mental Health Association and current national President and CEO of Big Brothers Big Sisters of Canada.
More


Click here for news archive